TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,042,940 | +55.7% | 54,175 | +56.6% | 0.00% | – |
| Q2 2023 | $1,311,885 | +5687.9% | 34,587 | +3611.1% | 0.00% | – |
| Q1 2023 | $22,666 | +41.7% | 932 | +69.1% | 0.00% | – |
| Q4 2022 | $16,001 | +433.4% | 551 | +451.0% | 0.00% | – |
| Q3 2022 | $3,000 | -91.2% | 100 | -89.2% | 0.00% | – |
| Q2 2022 | $34,000 | +41.7% | 925 | +71.6% | 0.00% | – |
| Q1 2022 | $24,000 | -38.5% | 539 | -30.5% | 0.00% | – |
| Q4 2021 | $39,000 | +21.9% | 775 | +56.2% | 0.00% | – |
| Q3 2021 | $32,000 | -90.4% | 496 | -89.3% | 0.00% | – |
| Q2 2021 | $333,000 | -16.3% | 4,631 | -14.1% | 0.00% | – |
| Q1 2021 | $398,000 | -6.1% | 5,392 | -6.6% | 0.00% | – |
| Q4 2020 | $424,000 | -88.7% | 5,775 | -91.5% | 0.00% | -100.0% |
| Q3 2020 | $3,738,000 | +20.9% | 68,160 | +46.6% | 0.00% | 0.0% |
| Q2 2020 | $3,092,000 | +1188.3% | 46,505 | +1086.4% | 0.00% | – |
| Q1 2020 | $240,000 | +6.2% | 3,920 | +52.5% | 0.00% | – |
| Q4 2019 | $226,000 | -37.4% | 2,570 | -46.3% | 0.00% | – |
| Q3 2019 | $361,000 | -66.4% | 4,785 | -62.0% | 0.00% | – |
| Q2 2019 | $1,076,000 | +454.6% | 12,588 | +601.7% | 0.00% | – |
| Q1 2019 | $194,000 | +43.7% | 1,794 | +12.8% | 0.00% | – |
| Q4 2018 | $135,000 | +43.6% | 1,591 | +67.8% | 0.00% | – |
| Q3 2018 | $94,000 | -57.7% | 948 | -50.6% | 0.00% | – |
| Q2 2018 | $222,000 | -62.1% | 1,918 | -67.6% | 0.00% | – |
| Q1 2018 | $585,000 | -10.0% | 5,926 | -4.5% | 0.00% | – |
| Q4 2017 | $650,000 | -35.3% | 6,202 | -30.4% | 0.00% | – |
| Q3 2017 | $1,005,000 | +28.8% | 8,917 | +28.0% | 0.00% | – |
| Q2 2017 | $780,000 | -64.1% | 6,964 | -62.6% | 0.00% | -100.0% |
| Q1 2017 | $2,172,000 | -1.1% | 18,617 | -10.8% | 0.00% | 0.0% |
| Q4 2016 | $2,197,000 | +15.1% | 20,876 | +20.8% | 0.00% | 0.0% |
| Q3 2016 | $1,909,000 | +81.3% | 17,277 | +139.0% | 0.00% | 0.0% |
| Q2 2016 | $1,053,000 | +244.1% | 7,229 | +238.3% | 0.00% | – |
| Q1 2016 | $306,000 | -77.5% | 2,137 | -75.8% | 0.00% | -100.0% |
| Q4 2015 | $1,362,000 | -12.5% | 8,813 | -19.1% | 0.00% | 0.0% |
| Q3 2015 | $1,557,000 | +59.0% | 10,897 | +60.0% | 0.00% | 0.0% |
| Q2 2015 | $979,000 | -60.4% | 6,811 | -61.2% | 0.00% | -50.0% |
| Q1 2015 | $2,474,000 | +106.2% | 17,538 | +116.7% | 0.00% | +100.0% |
| Q4 2014 | $1,200,000 | – | 8,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |